The Cost to Medicare of Bladder Cancer CareFrank A. Sloan, Brant A. Inman, Arseniy Yashkin et al.|European Urology Oncology|2019Cited by 72
Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter TrialYair Lotan, Stephen A. Boorjian, Leah Davis et al.|The Journal of Urology|2019Cited by 27
Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Seth P. Lerner, Trine Strandgaard et al.|iScience|2024Cited by 12